Your browser doesn't support javascript.
loading
Dynamics of mcr-1 prevalence and mcr-1-positive Escherichia coli after the cessation of colistin use as a feed additive for animals in China: a prospective cross-sectional and whole genome sequencing-based molecular epidemiological study.
Shen, Cong; Zhong, Lan-Lan; Yang, Yongqiang; Doi, Yohei; Paterson, David L; Stoesser, Nicole; Ma, Furong; El-Sayed Ahmed, Mohamed Abd El-Gawad; Feng, Siyuan; Huang, Songyin; Li, Hong-Yu; Huang, Xi; Wen, Xin; Zhao, Zihan; Lin, Minmin; Chen, Guanping; Liang, Wanfei; Liang, Yingjian; Xia, Yong; Dai, Min; Chen, Ding-Qiang; Zhang, Liyan; Liao, Kang; Tian, Guo-Bao.
Afiliação
  • Shen C; Department of Microbiology, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, China; Key Laboratory of Tropical Diseases Control, Sun Yat-sen University, Ministry of Education, Guangzhou, China.
  • Zhong LL; Department of Microbiology, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, China; Key Laboratory of Tropical Diseases Control, Sun Yat-sen University, Ministry of Education, Guangzhou, China.
  • Yang Y; Department of Microbiology, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, China; School of Pharmaceutical Sciences Shenzhen, Sun Yat-sen University, Guangzhou, China; Key Laboratory of Tropical Diseases Control, Sun Yat-sen University, Ministry of Education, Guangzhou, China.
  • Doi Y; University of Pittsburgh School of Medicine, Pittsburgh, PA, USA; Department of Microbiology, Fujita Health University School of Medicine, Aichi, Japan; Department of Infectious Diseases, Fujita Health University School of Medicine, Aichi, Japan.
  • Paterson DL; University of Queensland Centre for Clinical Research, The University of Queensland, Brisbane, QLD, Australia.
  • Stoesser N; Modernising Medical Microbiology, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
  • Ma F; Department of Clinical Laboratory Medicine, Third Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.
  • El-Sayed Ahmed MAE; Department of Microbiology, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, China; Key Laboratory of Tropical Diseases Control, Sun Yat-sen University, Ministry of Education, Guangzhou, China; Department of Microbiology and Immunology, Faculty of Pharmaceutical Sciences and Drug Man
  • Feng S; Department of Microbiology, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, China; Key Laboratory of Tropical Diseases Control, Sun Yat-sen University, Ministry of Education, Guangzhou, China.
  • Huang S; Department of Clinical Laboratory, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China.
  • Li HY; Department of Clinical Laboratory, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China.
  • Huang X; Program of Pathobiology and Immunology, Fifth Affiliated Hospital of Sun Yat-sen University, Sun Yat-sen University, Zhuhai, China.
  • Wen X; Department of Microbiology, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, China; Key Laboratory of Tropical Diseases Control, Sun Yat-sen University, Ministry of Education, Guangzhou, China.
  • Zhao Z; Department of Microbiology, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, China; Key Laboratory of Tropical Diseases Control, Sun Yat-sen University, Ministry of Education, Guangzhou, China.
  • Lin M; Department of Respiratory Medicine, Fifth Affiliated Hospital of Sun Yat-sen University, Sun Yat-sen University, Zhuhai, China.
  • Chen G; Department of Microbiology, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, China; Key Laboratory of Tropical Diseases Control, Sun Yat-sen University, Ministry of Education, Guangzhou, China.
  • Liang W; Department of Microbiology, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, China; Key Laboratory of Tropical Diseases Control, Sun Yat-sen University, Ministry of Education, Guangzhou, China.
  • Liang Y; Department of Respiratory Medicine, Fifth Affiliated Hospital of Sun Yat-sen University, Sun Yat-sen University, Zhuhai, China.
  • Xia Y; Department of Clinical Laboratory Medicine, Third Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.
  • Dai M; School of Laboratory Medicine, Chengdu Medical College, Chengdu, China.
  • Chen DQ; Division of Laboratory Medicine, Zhujiang Hospital, Southern Medical University, Guangzhou, Guangdong, China.
  • Zhang L; Department of Clinical Laboratory, Guangdong Provincial People's Hospital and Guangdong Academy of Medical Sciences, Guangzhou, Guangdong, China.
  • Liao K; Department of Clinical Laboratory, First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China.
  • Tian GB; Department of Microbiology, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, China; Key Laboratory of Tropical Diseases Control, Sun Yat-sen University, Ministry of Education, Guangzhou, China. Electronic address: tiangb@mail.sysu.edu.cn.
Lancet Microbe ; 1(1): e34-e43, 2020 May.
Article em En | MEDLINE | ID: mdl-35538907
ABSTRACT

BACKGROUND:

The global dissemination of colistin resistance encoded by mcr-1 has been attributed to extensive use of colistin in livestock, threatening colistin efficacy in medicine. The emergence of mcr-1 in common pathogens, such as Escherichia coli, is of particular concern. China banned the use of colistin in animal feed from May 1, 2017. We investigated subsequent changes in mcr-1 prevalence in animals, humans, food, and the environment, and the genomic epidemiology of mcr-1-positive E coli (MCRPEC).

METHODS:

Sampling was done before (October to December, 2016) and after (October to December, 2017, and 2018, respectively) the colistin ban. 3675 non-duplicate pig faecal samples were collected from 14 provinces (66 farms) in China to measure intervention-related changes in mcr-1 prevalence. 15 193 samples were collected from pigs, healthy human volunteers, patients colonised or infected with Enterobacteriaceae who were admitted to hospital, food and the environment in Guangzhou, to characterise source-specific mcr-1 prevalence and the wider ecological effect of the ban. From these samples, 688 MCRPEC were analysed with whole genome sequencing, plasmid conjugation, and S1 pulsed-field gel electrophoresis with Southern blots to characterise associated genomic changes.

FINDINGS:

After the ban, mcr-1 prevalence decreased significantly in national pig farms, from 308 (45%) of 684 samples in 2016 to 274 (19%) of 1416 samples in 2018 (p<0·0001). A similar decrease occurred in samples from most sources in Guangzhou (959 [19%] of 5003 samples in 2016; 238 [5%] of 4489 samples in 2018; p<0·0001). The population structure of MCRPEC was diverse (23 sequence clusters); sequence type 10 clonal complex isolates were predominant (247 [36%] of 688). MCRPEC causing infection in patients admitted to hospital were genetically more distinct and appeared less affected by the ban. mcr-1 was predominantly found on plasmids (632 [92%] of 688). Common mcr-1 plasmid types included IncX4, IncI2, and IncHI2 (502 [76%] of 656); significant increases in IncI2-associated mcr-1 and a distinct lineage of mcr-1-associated IncHI2 were observed post ban. Changes in the frequency of mcr-1-associated flanking sequences (ISApl1-negative MCRPEC), 63 core genome single nucleotide polymorphisms, and 30 accessory genes were also significantly different after the ban (Benjamini-Hochberg-adjusted p<0·05), consistent with rapid genetic adaptation in response to changing selection pressures.

INTERPRETATION:

A rapid, ecosystem-wide, decline in mcr-1 was observed after the use of colistin in animal feed was banned, with associated genetic changes in MCRPEC. Withdrawal of antimicrobials from animal feed should be an important One Health measure contributing to the wider control of antimicrobial resistance globally.

FUNDING:

National Natural Science Foundation of China.

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 3_ND Base de dados: MEDLINE Tipo de estudo: Prevalence_studies / Risk_factors_studies Idioma: En Revista: Lancet Microbe Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 3_ND Base de dados: MEDLINE Tipo de estudo: Prevalence_studies / Risk_factors_studies Idioma: En Revista: Lancet Microbe Ano de publicação: 2020 Tipo de documento: Article